The present invention relates to immunogenic compositions, such as vaccines,comprising immunogenic polypeptidesfrom Haemophilus influenzae and Moraxellacatarrhalis, for use in methodsofboosting an immune response and methods of treatmentusing same. More particularly, the invention relates to use of suchimmunogenic compositions in methods of treating or preventingexacerbation of chronic obstructive pulmonary disease.